Key Takeaways
- FSSAI said a Nestlé Low Fat Dairy Whitener sample collected from The Lalit in New Delhi was declared unsafe and substandard.
- The food regulator directed the food business operator to immediately prohibit the sale of the identified product.
- FSSAI said the operator has an opportunity to appeal the Food Analyst's report under the Food Safety and Standards Act, 2006.
FSSAI Flags Nestlé Low Fat Dairy Whitener Sample
The Food Safety and Standards Authority of India (FSSAI) has classified a sample of Nestlé’s Low Fat Dairy Whitener collected from The Lalit hotel in New Delhi as “unsafe” and “substandard.” The regulator announced the finding on October 3, 2026, through its official communication.
According to FSSAI, the sample was collected from M/s Bharat Hotels Ltd., which operates The Lalit in Connaught Place, New Delhi. The regulator said Food Analyst reports issued under the Food Safety and Standards Act, 2006, declared the sample unsafe and substandard.
Sale of Identified Product Ordered to Stop
Following the laboratory finding, FSSAI directed the food business operator to immediately prohibit the sale of the identified product.
The regulator also said a copy of the laboratory analysis report had been provided to the food business operator for reference and necessary action. The announcement does not publicly identify the specific laboratory parameter, contaminant or technical defect that resulted in the sample receiving both classifications.
This distinction is important because the available official communication establishes the regulatory finding, but does not provide enough technical information to determine exactly why the particular sample failed laboratory assessment.
What FSSAI Standards Say About Dairy Whitener
FSSAI maintains specific standards for dairy whitener under India's food regulations. The official standard covers different categories, including skimmed milk dairy whitener, low-fat dairy whitener, medium-fat dairy whitener and high-fat dairy whitener.
For low-fat dairy whitener, the applicable standard specifies milk fat of more than 1.5% and less than 10%. It also sets requirements for milk protein, moisture and the insolubility index.
However, these general standards should not be interpreted as identifying the reason behind the current Nestlé sample's classification. FSSAI has not publicly disclosed the relevant failed parameter in its October 3 announcement.
Appeal Process Remains Available
FSSAI said the food business operator has an opportunity to appeal against the Food Analyst’s report under the applicable provisions of the Food Safety and Standards Act, 2006, within the prescribed period.
That means the October 3 announcement represents a regulatory finding and immediate sale restriction concerning the identified sample, while the applicable legal process can continue through the available appeal mechanism.
The publicly available FSSAI communication also does not establish that every Nestlé Low Fat Dairy Whitener product or every batch is affected by this particular finding. The action specifically concerns the sample collected from the identified premises.
TwikUp's Perspective
The key issue for consumers is the difference between a confirmed regulatory finding and assumptions about the wider product category. FSSAI has clearly identified the sampled product, the location from which it was collected and the immediate action ordered. But without the detailed laboratory findings, broader conclusions about the cause or scale of the issue would go beyond the information officially released.
For readers, the most useful development to watch is the next stage of the regulatory process, including any appeal, clarification or publication of additional laboratory information.
What Comes Next
The immediate direction is for the identified product to remain off sale at the concerned food business operator while the regulatory process proceeds.
Further information from FSSAI could clarify the laboratory parameter involved and provide greater context about the finding. Until such information is officially released, the available facts remain limited to the specific sample and regulatory action announced on October 3.